{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:17Z","timestamp":1707524597599},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,29]]},"DOI":"10.7759\/cureus.26421","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T12:13:54Z","timestamp":1656504834000},"source":"Crossref","is-referenced-by-count":0,"title":["Peritoneal Carcinomatosis as an Initial Presentation of Gastrointestinal Stromal Tumor: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Gonca","family":"Ozcan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garima","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica C","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Perosevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-015-0526-8","article-title":"The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines","volume":"19","author":"Nishida T","year":"2016","unstructured":"Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2016, 19:3-14. 10.1007\/s10120-015-0526-8","journal-title":"Gastric Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.10.031","article-title":"Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies","volume":"40","author":"S\u00f8reide K","year":"2016","unstructured":"S\u00f8reide K, Sandvik OM, S\u00f8reide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016, 40:39-46. 10.1016\/j.canep.2015.10.031","journal-title":"Cancer Epidemiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61857-1","article-title":"Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"381","author":"Demetri GD","year":"2013","unstructured":"Demetri GD, Reichardt P, Kang YK, et al.. Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013, 381:295-302. 10.1016\/S0140-6736(12)61857-1","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00254-5","article-title":"Gastrointestinal stromal tumours","volume":"7","author":"Blay JY","year":"2021","unstructured":"Blay JY, Kang YK, Nishida T, von Mehren M. Gastrointestinal stromal tumours. Nat Rev Dis Primers. 2021, 7:22. 10.1038\/s41572-021-00254-5","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246958","article-title":"Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network","volume":"16","author":"de Pinieux G","year":"2021","unstructured":"de Pinieux G, Karanian M, Le Loarer F, et al.. Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network. PLoS One. 2021, 16:e0246958. 10.1371\/journal.pone.0246958","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1148\/rg.262055097","article-title":"Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib","volume":"26","author":"Hong X","year":"2006","unstructured":"Hong X, Choi H, Loyer EM, Benjamin RS, Trent JC, Charnsangavej C. Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radiographics. 2006, 26:481-95. 10.1148\/rg.262055097","journal-title":"Radiographics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy095","article-title":"Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Casali PG","year":"2018","unstructured":"Casali PG, Abecassis N, Aro HT, et al.. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018, 29:iv68-78. 10.1093\/annonc\/mdy095","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.05.140","article-title":"Biology of gastrointestinal stromal tumors","volume":"22","author":"Corless CL","year":"2004","unstructured":"Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol. 2004, 22:3813-25. 10.1200\/JCO.2004.05.140","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2009.00983.x","article-title":"Imatinib treatment for gastrointestinal stromal tumour (GIST)","volume":"14","author":"Lopes LF","year":"2010","unstructured":"Lopes LF, Bacchi CE. Imatinib treatment for gastrointestinal stromal tumour (GIST). J Cell Mol Med. 2010, 14:42-50. 10.1111\/j.1582-4934.2009.00983.x","journal-title":"J Cell Mol Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds587","article-title":"Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial","volume":"24","author":"Patrikidou A","year":"2013","unstructured":"Patrikidou A, Chabaud S, Ray-Coquard I, et al.. Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial. Ann Oncol. 2013, 24:1087-93. 10.1093\/annonc\/mds587","journal-title":"Ann Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.1617","article-title":"Use of PD-1 targeting, macrophage infiltration, and IDO pathway activation in sarcomas: a phase 2 clinical trial","volume":"4","author":"Toulmonde M","year":"2018","unstructured":"Toulmonde M, Penel N, Adam J, et al.. Use of PD-1 targeting, macrophage infiltration, and IDO pathway activation in sarcomas: a phase 2 clinical trial. JAMA Oncol. 2018, 4:93-7. 10.1001\/jamaoncol.2017.1617","journal-title":"JAMA Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.12.008","article-title":"Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: long-term efficacy and safety data from the NAVIGATOR phase I trial","volume":"145","author":"Jones RL","year":"2021","unstructured":"Jones RL, Serrano C, von Mehren M, et al.. Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: long-term efficacy and safety data from the NAVIGATOR phase I trial. Eur J Cancer. 2021, 145:132-42. 10.1016\/j.ejca.2020.12.008","journal-title":"Eur J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30269-2","article-title":"Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial","volume":"21","author":"Heinrich MC","year":"2020","unstructured":"Heinrich MC, Jones RL, von Mehren M, et al.. Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial. Lancet Oncol. 2020, 21:935-946. 10.1016\/S1470-2045(20)30269-2","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong DS","year":"2020","unstructured":"Hong DS, DuBois SG, Kummar S, et al.. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol. 2020, 21:531-40. 10.1016\/S1470-2045(19)30856-3","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000650","article-title":"Tropomyosin receptor kinase inhibitors in the management of sarcomas","volume":"32","author":"Wilding CP","year":"2020","unstructured":"Wilding CP, Loong HH, Huang PH, Jones RL. Tropomyosin receptor kinase inhibitors in the management of sarcomas. Curr Opin Oncol. 2020, 32:307-13. 10.1097\/CCO.0000000000000650","journal-title":"Curr Opin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/101142-peritoneal-carcinomatosis-as-an-initial-presentation-of-gastrointestinal-stromal-tumor-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:05Z","timestamp":1707507845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/101142-peritoneal-carcinomatosis-as-an-initial-presentation-of-gastrointestinal-stromal-tumor-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,29]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.26421","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,29]]}}}